CareDx, Inc. (CDNA)
77.88
-1.93
(-2.42%)
USD |
NASDAQ |
Nov 13, 16:00
77.00
-0.88
(-1.13%)
After-Hours: 19:59
CareDx Enterprise Value : 3.864B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.864B |
| November 12, 2026 | 3.965B |
| November 11, 2026 | 4.037B |
| November 10, 2026 | 4.016B |
| November 09, 2026 | 4.207B |
| November 06, 2026 | 3.900B |
| November 05, 2026 | 3.783B |
| November 04, 2026 | 4.283B |
| November 03, 2026 | 4.420B |
| November 02, 2026 | 4.284B |
| October 30, 2026 | 4.364B |
| October 29, 2026 | 3.531B |
| October 28, 2026 | 3.563B |
| October 27, 2026 | 3.479B |
| October 26, 2026 | 3.404B |
| October 23, 2026 | 3.409B |
| October 22, 2026 | 3.407B |
| October 21, 2026 | 3.490B |
| October 20, 2026 | 3.409B |
| October 19, 2026 | 3.298B |
| October 16, 2026 | 3.136B |
| October 15, 2026 | 3.276B |
| October 14, 2026 | 3.172B |
| October 13, 2026 | 3.211B |
| October 12, 2026 | 3.090B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.119B |
| October 08, 2026 | 3.042B |
| October 07, 2026 | 3.086B |
| October 06, 2026 | 3.125B |
| October 05, 2026 | 3.443B |
| October 02, 2026 | 3.301B |
| October 01, 2026 | 3.253B |
| September 30, 2026 | 3.188B |
| September 29, 2026 | 2.942B |
| September 28, 2026 | 2.971B |
| September 25, 2026 | 2.924B |
| September 24, 2026 | 2.805B |
| September 23, 2026 | 2.442B |
| September 22, 2026 | 2.554B |
| September 21, 2026 | 2.443B |
| September 18, 2026 | 2.417B |
| September 17, 2026 | 2.440B |
| September 16, 2026 | 2.402B |
| September 15, 2026 | 2.356B |
| September 14, 2026 | 2.342B |
| September 11, 2026 | 2.233B |
| September 10, 2026 | 2.221B |
| September 09, 2026 | 2.221B |
| September 08, 2026 | 2.236B |
| September 04, 2026 | 2.265B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 45.20B |
| Myriad Genetics, Inc. | 643.96M |
| BioRestorative Therapies, Inc. | -1.659M |
| Exagen, Inc. | 105.65M |
| Sera Prognostics, Inc. | 39.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.29M |
| Revenue (Quarterly) | 139.36M |
| Total Expenses (Quarterly) | 120.07M |
| EPS Diluted (Quarterly) | 0.3509 |
| Gross Profit Margin (Quarterly) | 70.51% |
| Profit Margin (Quarterly) | 13.84% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 0.10% |
| Normalized Earnings Yield | 3.087 |